- Home
- ALT vs WEYS Comparison
ALT vs WEYS Comparison
Compare ALT & WEYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALT
- WEYS
- Stock Information
- Founded
- ALT 1997
- WEYS 1906
- Country
- ALT United States
- WEYS United States
- Employees
- ALT N/A
- WEYS N/A
- Industry
- ALT Biotechnology: Pharmaceutical Preparations
- WEYS Apparel
- Sector
- ALT Health Care
- WEYS Consumer Staples
- Exchange
- ALT Nasdaq
- WEYS Nasdaq
- Market Cap
- ALT 333.6M
- WEYS 294.5M
- IPO Year
- ALT N/A
- WEYS N/A
- Fundamental
- Price
- ALT $3.93
- WEYS $28.92
- Analyst Decision
- ALT Strong Buy
- WEYS
- Analyst Count
- ALT 6
- WEYS 0
- Target Price
- ALT $17.40
- WEYS N/A
- AVG Volume (30 Days)
- ALT 3.0M
- WEYS 14.3K
- Earning Date
- ALT 11-11-2025
- WEYS 11-04-2025
- Dividend Yield
- ALT N/A
- WEYS 3.73%
- EPS Growth
- ALT N/A
- WEYS N/A
- EPS
- ALT N/A
- WEYS 2.69
- Revenue
- ALT $20,000.00
- WEYS $281,051,000.00
- Revenue This Year
- ALT N/A
- WEYS N/A
- Revenue Next Year
- ALT N/A
- WEYS N/A
- P/E Ratio
- ALT N/A
- WEYS $10.65
- Revenue Growth
- ALT N/A
- WEYS N/A
- 52 Week Low
- ALT $2.90
- WEYS $25.51
- 52 Week High
- ALT $11.16
- WEYS $41.05
- Technical
- Relative Strength Index (RSI)
- ALT 52.80
- WEYS 38.70
- Support Level
- ALT $3.85
- WEYS $29.61
- Resistance Level
- ALT $4.06
- WEYS $30.41
- Average True Range (ATR)
- ALT 0.20
- WEYS 0.80
- MACD
- ALT 0.02
- WEYS -0.11
- Stochastic Oscillator
- ALT 57.35
- WEYS 0.00
About ALT Altimmune Inc.
Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.
About WEYS Weyco Group Inc.
Weyco Group Inc is a company, engaged in the manufacturing, designing, and distribution of footwear. The company designs and markets footwear for men, women, and children. It markets its apparel, accessories, and footwear under the brand names of Florsheim, Nunn Bush, Stacy Adams, BOGS, Rafters, and Forsake. The company organizes its business into two segments; the North American wholesale operations and the North American retail operations. The majority of the company's revenue is generated from the wholesale segment under which its products are sold to footwear, department, and specialty stores, as well as e-commerce retailers. The company has operational footprints in the United States which generates key revenue, Canada, Asia, South Africa, and Australia.